PPD teams with DiabetesAmerica to boost recruitment capacity
US CRO PPD will add a database of 16,000 patients to its portfolio in an exclusive services deal with Houston-based care organisation DiabetesAmerica.
Archives for December 21, 2009
Hospira to buy injectables biz from India’s Orchid
Hospira will pay India’s Orchid Chemicals and Pharmaceuticals approximately $400m (€278m) for its generic injectables business.
Geron and Novocell set for stem cell tech patent battle
Geron says the USPTO appeals board granted a request to declare “interference” between a patent application owned by the firm and one issued to Novocell in March.
Merck & Co to buy Avecia Biologics
US drug major Merck & Co will buy into the UK's contract biologics manufacturing sector with the acquisition of Tees Valley-based Avecia Biologics.
Jubilant plans new niacinamide facility
Jubilant Organosys will build a new niacinamide and 3-Cyanopyridine plant to cater for growing demand in the drug and nutrition industries.
NexMed stays on Nasdaq after Bio-Quant buy
US drugmaker NexMed has maintained its place on the Nasdaq Stock Exchange, partly as a result of its acquisition of US preclinical CRO Bio-Quant.
India's focus on APIs and generics helped growth in 2009
The Indian pharmaceutical market was worth $10.8bn (€7.5bn) this year and will more than double in value by 2014 according to a new industry report by Cygnus Business Consulting & Research.
Kendle opts for MetricStream for compliance management
Trials contractor Kendle International will use a management platform developed by US software group MetricStream to help control its global compliance and quality assurance operations.
Seasonal Video Greetings From Decision News Media
Welcome to this seasonal holiday video from Decision News Media.As we prepare to celebrate our tenth anniversary next year and first year as part of William Reed Business Media, we present 10 fun number facts about our company. And, later this week, the...